Other Transaction Agreement HR0011269E092
Award Date 2/20/26
Potential Completion Date 11/19/26
Potential Value $682K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
Not listed Extent Competed
Competed
Major Defense Program
Not listed Pricing Type
Other
Place of Performance
Minneapolis, MN 55401, USA
Solicitation Procedures
Program Solicitation
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The U.S. Defense Advanced Research Projects Agency (DARPA) awarded a $371,091.00 Other Transaction Agreement to Sequre DX Inc., a for-profit organization, for the "EXPERIMENTAL OPTIMIZATION AND COMMERCIALIZATION OF GENE EDITOR OFFTARGET ASSAYS" project. The contract is for work to be performed in Boston, MA and has a completion date of September 30, 2021. This contract is not set aside for any specific business type.</p>
- <p>This is a $149,998.88 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to De Novo DNA, a self-certified small disadvantaged business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for "HIGHLY SCALABLE MULTIPLEXED CRISPR APPLICATIONS USING ADVANCED PART TOOLBOXES AND CIRCUITS" and has an ultimate completion date of October 7, 2018. The contract is designated as a Total Small Business set-aside.</p>
- <p>This is a $1,509,952.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to All Things Bugs LLC, a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for new technology and genetically engineered insects for sustainable food, nutrition, health, and other applications. The contract has an ultimate completion date of August 24, 2021 and was awarded on June 25, 2018.</p>
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to B-Mogen Biotechnologies Inc. for the development of "NEXT GENERATION GENOME EDITING TOOLS." The contract is a firm-fixed-price definitive contract with a ceiling value of $149,431.43 and a period of performance ending on April 20, 2018. As an SBIR Phase I award, this contract is focused on the research and development of innovative technologies that...
- This is a definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to MRIGlobal, a 501(c)(3) not-for-profit research organization. The $37,048,565 cost-plus-fixed-fee contract is for research in support of DARPA's DIGET program, without any set-aside designation. MRIGlobal has subcontracted with several vendors, including Integrated DNA Technologies (IDT), Applied Microarrays, LLC, Natech Plastics Inc., The Charles Stark Draper Laboratory, Inc., University of...
- The Defense Advanced Research Projects Agency (DARPA) awarded an Other Transaction Agreement valued at $485.5K to Decycle Biosystems, Inc. (doing business as Decycle Bio) on December 1, 2025, for a project titled "Enabling Rapid Agrochemical Countermeasures by Designing and Engineering Novel Enzymes and Biosynthetic Pathways." The contract is scheduled for completion by August 31, 2026, with work to be performed at the contractor's facility in Seattle, Washington. This effort aligns...
- This is a $699,679 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ecovative, a for-profit limited liability company, for the Biological Robustness in Complex Settings (BRICS) Phase I effort. The contract is for the cohabitation of a genetically modified microbial community. The contract does not have a set-aside designation and was awarded on December 4, 2015, with a completion date of December 7, 2017. DARPA is the funding agency for this...
- The Defense Advanced Research Projects Agency (DARPA) awarded a $692,875 firm fixed-price definitive contract to The Council on Strategic Risks on October 21, 2025, for work under the Biological Technologies Office's SWITCH Program. The contract will be performed in Washington, DC and is scheduled for completion by February 20, 2028. No set-aside designation was utilized for this award. The SWITCH Program represents DARPA's investment in biological technology research and development with...
- This federal contract award was issued by the Defense Advanced Research Projects Agency (DARPA) to the Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, for a study titled "Achieving Closed-Loop RNA-Based PID Control with a Cell-Free Testbed." The contract has a ceiling value of $2,198,165.00 and a completion date of December 31, 2018. It is a definitive contract with a cost-no-fee pricing type. The contract does not have a...
- The Defense Advanced Research Projects Agency (DARPA) awarded Antares Systems Inc. a $500,000 Other Transaction Agreement for the MORPH Seedling Project, effective January 20, 2026, with an ultimate completion date of May 20, 2026. The contract will be performed in San Francisco, California. This award represents DARPA's investment in innovative research and development efforts, consistent with the agency's mission to pursue high-risk, high-reward technological advancement for defense...